HIIFS
FLGT icon

Harel Insurance Investments & Financial Services’s Fulgent Genetics FLGT Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,302
Closed -$131K – 741
2021
Q4 		$131K Sell
1,302
-14,816
-92% -$1.3M ﹤0.01% 469
2021
Q3 		$1.45M Buy
16,118
+816
+5% +$74.2K 0.04% 116
2021
Q2 		$4.33M Sell
15,302
-200
-1% -$16K 0.1% 105
2021
Q1 		$4.71M Sell
15,502
-5,798
-27% -$599K 0.09% 140
2020
Q4 		$3.57M Buy
21,300
+3,421
+19% +$143K 0.08% 114
2020
Q3 		$716K Buy
+17,879
New +$560K 0.02% 152

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Harel Insurance Investments & Financial Services's FLGT Position: Q1 2022 in Review

Harel Insurance Investments & Financial Services sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 1,302 shares — an estimated $131K sold.

Harel Insurance Investments & Financial Services first reported a position in FLGT in Q3 2020 and held it in 6 quarters. The position peaked at $4.71M in Q1 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • Harel Insurance Investments & Financial Services reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,302 Fulgent Genetics shares in Q1 2022, an estimated $131K.
  • Harel Insurance Investments & Financial Services first reported a position in Fulgent Genetics in Q3 2020 and held it in 6 quarters.
  • Harel Insurance Investments & Financial Services's Fulgent Genetics position peaked at $4.71M in Q1 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2022, filed 3 May 2022.